These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7622296)

  • 1. Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes.
    Allen TM; Newman MS; Woodle MC; Mayhew E; Uster PS
    Int J Cancer; 1995 Jul; 62(2):199-204. PubMed ID: 7622296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
    Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D
    Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.
    Mayer LD; Bally MB; Loughrey H; Masin D; Cullis PR
    Cancer Res; 1990 Feb; 50(3):575-9. PubMed ID: 2297698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
    Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
    Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma.
    Tokudome Y; Oku N; Doi K; Namba Y; Okada S
    Biochim Biophys Acta; 1996 Feb; 1279(1):70-4. PubMed ID: 8624364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy.
    Siegal T; Horowitz A; Gabizon A
    J Neurosurg; 1995 Dec; 83(6):1029-37. PubMed ID: 7490617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes.
    Vaage J; Donovan D; Mayhew E; Uster P; Woodle M
    Int J Cancer; 1993 Jul; 54(6):959-64. PubMed ID: 8335404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of vincristine-polyanion complexes in STEALTH liposomes on pharmacokinetics, toxicity and anti tumor activity.
    Zhu G; Oto E; Vaage J; Quinn Y; Newman M; Engbers C; Uster P
    Cancer Chemother Pharmacol; 1996; 39(1-2):138-42. PubMed ID: 8995511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis and therapy of mouse mammary carcinomas with doxorubicin and vincristine encapsulated in sterically stabilised liposomes.
    Vaage J; Donovan D; Loftus T; Uster P; Working P
    Eur J Cancer; 1995; 31A(3):367-72. PubMed ID: 7786604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Release profile of compound liposomes entrapped with vincristine sulfate and mitoxantrone chlorhydric acid in vitro and their distribution in mice].
    Chen T; Hou SX; Wang YY; Zhang WS; Chen DH
    Yao Xue Xue Bao; 2006 Dec; 41(12):1170-5. PubMed ID: 17290615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
    Nogae I; Kikuchi J; Yamaguchi T; Nakagawa M; Shiraishi N; Kuwano M
    Br J Cancer; 1987 Sep; 56(3):267-72. PubMed ID: 3663474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors.
    Leonetti C; Scarsella M; Semple SC; Molinari A; D'Angelo C; Stoppacciaro A; Biroccio A; Zupi G
    Int J Cancer; 2004 Jul; 110(5):767-74. PubMed ID: 15146568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and antitumor activity of vincristine entrapped in vesicular phospholipid gels.
    Güthlein F; Burger AM; Brandl M; Fiebig HH; Schubert R; Unger C; Massing U
    Anticancer Drugs; 2002 Sep; 13(8):797-805. PubMed ID: 12394263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine.
    Kato T; Suzumura Y
    J Natl Cancer Inst; 1987 Sep; 79(3):527-32. PubMed ID: 3476792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
    J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
    Shinoda H; Inaba M; Tsuruo T
    Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
    Webb MS; Harasym TO; Masin D; Bally MB; Mayer LD
    Br J Cancer; 1995 Oct; 72(4):896-904. PubMed ID: 7547237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors.
    Boman NL; Masin D; Mayer LD; Cullis PR; Bally MB
    Cancer Res; 1994 Jun; 54(11):2830-3. PubMed ID: 8187061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.
    Mayer LD; Nayar R; Thies RL; Boman NL; Cullis PR; Bally MB
    Cancer Chemother Pharmacol; 1993; 33(1):17-24. PubMed ID: 8269584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia.
    Silverman JA; Reynolds L; Deitcher SR
    J Clin Pharmacol; 2013 Nov; 53(11):1139-45. PubMed ID: 23907766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.